98%
921
2 minutes
20
Background: Acute myocardial infarction (AMI) occurs as a result of irreversible damage to cardiac myocytes secondary to lack of blood supply. Cardiogenic shock complicating AMI has significant associated morbidity and mortality, and data on postdischarge outcomes are limited.
Methods And Results: We derived the study cohort of patients with AMI and cardiogenic shock from the 2013 to 2014 Healthcare Cost and Utilization Project National Readmission Database. Incidence, predictors, and causes of 30-day readmissions were analyzed. From 43 212 index admissions for AMI with cardiogenic shock, 26 016 (60.2%) survived to discharge and 5277 (20.2% of survivors) patients were readmitted within 30 days. More than 50% of these readmissions occurred within first 10 days. Cardiac causes accounted for 42% of 30-day readmissions (heart failure 20.6%; acute coronary syndrome 11.6%). Among noncardiac causes, respiratory (11.4%), infectious (9.4%), medical or surgical care complications (6.3%), gastrointestinal/hepatobiliary (6.5%), and renal causes (4.8%) were most common. Length of stay ≥8 days (odds ratio [OR], 2.04; 95% confidence interval [CI], 1.70-2.44; <0.01), acute deep venous thrombosis (OR, 1.26; 95% CI, 1.08-1.48; <0.01), liver disease (OR, 1.25; 95% CI, 1.03-1.50; =0.02), systemic thromboembolism (OR, 1.21; 95% CI, 1.02-1.44; =0.02), peripheral vascular disease (OR, 1.16; 95% CI, 1.07-1.27; <0.01), diabetes mellitus (OR, 1.16; 95% CI, 1.08-1.24; <0.01), long-term ventricular assist device implantation (OR, 1.77; 95% CI, 1.23-2.55; <0.01), intraaortic balloon pump use (OR, 1.10; 95% CI, 1.02-1.18; <0.01), performance of coronary artery bypass grafting (OR, 0.85; 95% CI, 0.77-0.93; <0.01), private insurance (OR, 0.72; 95% CI, 0.64-0.80; <0.01), and discharge to home (OR, 0.85; 95% CI, 0.73-0.98; =0.03) were among the independent predictors of 30-day readmission.
Conclusions: In-hospital mortality and 30-day readmission in cardiogenic shock complicating AMI are significantly elevated. Patients are readmitted mainly for noncardiac causes. Identification of high-risk factors may guide interventions to improve outcomes within this population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004310 | DOI Listing |
Int J Cardiol
September 2025
Department of Cardiology, Hospital Universitario de La Princesa, IIS-IP, CIBER-CV, Universidad Autónoma Madrid, Madrid, Spain.
Int J Cardiol
September 2025
Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China. Electronic address:
Pediatr Cardiol
September 2025
Pediatric Cardiology Unit, University Hospital of Geneva, Geneva, Switzerland.
Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital anomaly. Its clinical course is typically severe in infancy, leading to left ventricular ischemia, cardiogenic shock, and high mortality without surgical intervention.We describe a rare case of a 3-year-old girl diagnosed with ALCAPA, showing extensive right-to-left collaterals, preserved left ventricular function, and minimal myocardial injury.
View Article and Find Full Text PDFUrol Case Rep
September 2025
Main Line Health, Division of Urology, Wynnewood, PA, USA.
Muscle-invasive bladder cancer (MIBC) with cardiac metastasis typically carries a very poor prognosis. A Black woman in her 70s developed high-grade urothelial carcinoma with squamous differentiation invading the bladder muscle. Despite chemotherapy, radiation, and nephrostomy, the disease progressed.
View Article and Find Full Text PDFCureus
August 2025
Emergency and Critical Care Center, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Haebaru, JPN.
The indications for extracorporeal membrane oxygenation (ECMO) have broadened in clinical practice, and its use in circulatory failure caused by acute drug intoxication has become more frequent. We reviewed three cases of venoarterial (VA) ECMO use for intoxication at our hospital. Three cases (aged 60-69 years) developed refractory shock following intentional overdose, including calcium channel blockers.
View Article and Find Full Text PDF